Second-line bismuth-containing quadruple therapy for Helicobacter pylori eradication and impact of diabetes

doi:10.3748/wjg.v23.i6.1059

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 23, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8949)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

562

WORD

326

HTML

4194

Figures (1-2)

722

Tables (1-3)

350

Sum=6154

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1105

Download

1690

Sum=2795

Feb 14, 2017 (publication date) through Dec 25, 2024

Times Cited of This Article

Times Cited (14)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Feb 14, 2017; 23(6): 1059-1066
Published online Feb 14, 2017. doi: 10.3748/wjg.v23.i6.1059

Full Size Figure Download Figure

Figure 1 Flowchart of the study participants. ITT: Intention-to-treat; PP: Per-protocol; H. pylori: Helicobacter pylori.

Citation: Kim SE, Park MI, Park SJ, Moon W, Kim JH, Jung K, Kim HK, Lee YD. Second-line bismuth-containing quadruple therapy for Helicobacter pylori eradication and impact of diabetes. World J Gastroenterol 2017; 23(6): 1059-1066
URL: https://www.wjgnet.com/1007-9327/full/v23/i6/1059.htm
DOI: https://dx.doi.org/10.3748/wjg.v23.i6.1059